Turner Christopher Durant, Chief Medical Officer of Nuvalent, Inc. ($NUVL), sold shares on the open market seven times in the last 365 days for a total of $721 thousand. His most recent sale occurred on January 6, 2026. These insider sales rank 5,662nd out of 11,678 individuals in the database, below the average of $8.6 million per insider and 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1321 | $96.75 | 56,990.0000 | 72,143,466 | 2.27% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 317 | $98.52 | 58,311.0000 | 72,143,466 | 0.54% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1929 | $97.96 | 58,628.0000 | 72,143,466 | 3.19% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1119 | $96.85 | 60,557.0000 | 72,143,466 | 1.81% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 871 | $96.06 | 61,676.0000 | 72,143,466 | 1.39% | 0.00% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 72,143,466 | 9999.99% | 0.02% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Class A Common Stock | 17500 | $0.00 | 72,630.0000 | 72,143,466 | 31.74% | 0.02% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 225 | $98.40 | 55,130.0000 | 72,143,466 | 0.41% | 0.00% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1635 | $97.33 | 55,355.0000 | 72,143,466 | 2.87% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Class A Common Stock | 18750 | $0.00 | 66,563.0000 | 66,408,807 | 39.22% | 0.03% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1152 | $78.28 | 65,411.0000 | 66,408,807 | 1.73% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 691 | $79.33 | 64,720.0000 | 66,408,807 | 1.06% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 2173 | $80.54 | 62,547.0000 | 66,408,807 | 3.36% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 66,408,807 | 9999.99% | 0.06% |
| Jan. 5, 2024 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 58,223,339 | 9999.99% | 0.08% |
| Jan. 5, 2024 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Class A Common Stock | 33300 | $0.00 | 47,813.0000 | 58,223,339 | 229.45% | 0.06% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 7995 | $0.00 | 303,105.0000 | 49,668,864 | 2.57% | 0.02% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 1465 | $57.70 | 14,513.0000 | 49,668,864 | 9.17% | 0.00% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 500 | $57.18 | 15,978.0000 | 49,668,864 | 3.03% | 0.00% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 500 | $55.84 | 16,478.0000 | 49,668,864 | 2.94% | 0.00% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 600 | $54.32 | 16,978.0000 | 49,668,864 | 3.41% | 0.00% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 2265 | $53.70 | 17,578.0000 | 49,668,864 | 11.41% | 0.00% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 2665 | $51.32 | 19,843.0000 | 49,668,864 | 11.84% | 0.01% |
| Oct. 4, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 7995 | $6.89 | 22,508.0000 | 49,668,864 | 55.09% | 0.02% |
| July 28, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 2665 | $6.89 | 17,178.0000 | 49,668,864 | 18.36% | 0.01% |
| July 26, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 2365 | $6.89 | 16,878.0000 | 49,668,864 | 16.30% | 0.00% |
| July 26, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 2365 | $46.85 | 14,513.0000 | 49,668,864 | 14.01% | 0.00% |
| July 28, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 2665 | $0.00 | 311,100.0000 | 49,668,864 | 0.85% | 0.01% |
| July 26, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 2365 | $0.00 | 313,765.0000 | 49,668,864 | 0.75% | 0.00% |
| July 28, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 2665 | $48.93 | 14,513.0000 | 49,668,864 | 15.51% | 0.01% |
| July 24, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 200 | $6.89 | 14,713.0000 | 49,668,864 | 1.38% | 0.00% |
| July 20, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 316,330.0000 | 49,668,864 | 0.03% | 0.00% |
| July 24, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 200 | $0.00 | 316,130.0000 | 49,668,864 | 0.06% | 0.00% |
| July 20, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 100 | $6.89 | 14,613.0000 | 49,668,864 | 0.69% | 0.00% |
| July 20, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 100 | $46.80 | 14,513.0000 | 49,668,864 | 0.68% | 0.00% |
| July 24, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 200 | $46.82 | 14,513.0000 | 49,668,864 | 1.36% | 0.00% |
| June 5, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Class A Common Stock | 10235 | $6.89 | 24,748.0000 | 49,668,864 | 70.52% | 0.02% |
| June 5, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | M | Stock Option (Right to Buy) | 10235 | $0.00 | 316,430.0000 | 49,668,864 | 3.13% | 0.02% |
| June 5, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | S | Class A Common Stock | 10235 | $44.86 | 14,513.0000 | 49,668,864 | 41.36% | 0.02% |
| Jan. 6, 2023 | Nuvalent, Inc. | $NUVL | Turner Christopher Durant | Chief Medical Officer | A | Stock Option (Right to Buy) | 144200 | $0.00 | 144,200.0000 | 49,668,864 | 9999.99% | 0.29% |